Status:
COMPLETED
Transillumination to Reduce Post-injection Complications in Aesthetic Medicine
Lead Sponsor:
Helynck, Patrick, M.D.
Conditions:
E05.642.500
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transillumination (TL) is a noninvasive technique that appears to allow preliminary detection of superficial vascular structures of the face to avoid intravascular HA injection. The purpose of our stu...
Detailed Description
Transillumination was used during the injection of hyaluronic acid to reduce the risk of intravascular injection. For the purpose of randomization, patients were asked to choose a sealed envelope. Ins...
Eligibility Criteria
Inclusion
- Patients presenting for facial injections of hyaluronic acid
Exclusion
- Patients with a history of allergy to a component of hyaluronic acid
- Patients with arteritis (Horton)
- Patients who have had previous facial surgery
- pregnant or nursing patients
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04750421
Start Date
March 1 2018
End Date
July 1 2018
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MEZI
Créteil, France, 94000